世界の多血小板血漿治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Platelet Rich Plasma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5307
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、多血小板血漿治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（P-PRP、L-PRF、L-PRP）、用途別市場規模（整形外科手術、美容整形、一般手術、その他手術）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・多血小板血漿治療の市場動向
・企業の競争状況、市場シェア
・多血小板血漿治療の種類別市場規模と予測2016-2027（P-PRP、L-PRF、L-PRP）
・多血小板血漿治療の用途別市場規模と予測2016-2027（整形外科手術、美容整形、一般手術、その他手術）
・多血小板血漿治療の北米市場規模2016-2027（アメリカ、カナダ）
・多血小板血漿治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・多血小板血漿治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多血小板血漿治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・多血小板血漿治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Harvest Technologies、DePuy Synthes、Stryker、Zimmer Biomet、Arthrex、Exactech、Emcyte Corporation、Arteriocyte、Adilyfe）
・結論

Platelet-rich plasma (PRP) therapy uses injections of a concentration of a patient’s own platelets to accelerate the healing of injured tendons, ligaments, muscles and joints. In this way, PRP injections use each individual patient’s own healing system to improve musculoskeletal problems.
The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.

Market Analysis and Insights: Global Platelet Rich Plasma Treatment Market
The global Platelet Rich Plasma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Platelet Rich Plasma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Platelet Rich Plasma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Platelet Rich Plasma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Platelet Rich Plasma Treatment market.

Global Platelet Rich Plasma Treatment Scope and Market Size
Platelet Rich Plasma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Platelet Rich Plasma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
P-PRP
L-PRF
L-PRP

Segment by Application
Orthopedic Surgery
Cosmetic Surgery
General Surgery
Other Surgeries

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Exactech
Emcyte Corporation
Arteriocyte
Adilyfe

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Platelet Rich Plasma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 P-PRP
1.2.3 L-PRF
1.2.4 L-PRP
1.3 Market by Application
1.3.1 Global Platelet Rich Plasma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Orthopedic Surgery
1.3.3 Cosmetic Surgery
1.3.4 General Surgery
1.3.5 Other Surgeries
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Platelet Rich Plasma Treatment Market Perspective (2016-2027)
2.2 Platelet Rich Plasma Treatment Growth Trends by Regions
2.2.1 Platelet Rich Plasma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Platelet Rich Plasma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Platelet Rich Plasma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Platelet Rich Plasma Treatment Industry Dynamic
2.3.1 Platelet Rich Plasma Treatment Market Trends
2.3.2 Platelet Rich Plasma Treatment Market Drivers
2.3.3 Platelet Rich Plasma Treatment Market Challenges
2.3.4 Platelet Rich Plasma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Platelet Rich Plasma Treatment Players by Revenue
3.1.1 Global Top Platelet Rich Plasma Treatment Players by Revenue (2016-2021)
3.1.2 Global Platelet Rich Plasma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Platelet Rich Plasma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Platelet Rich Plasma Treatment Revenue
3.4 Global Platelet Rich Plasma Treatment Market Concentration Ratio
3.4.1 Global Platelet Rich Plasma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Platelet Rich Plasma Treatment Revenue in 2020
3.5 Platelet Rich Plasma Treatment Key Players Head office and Area Served
3.6 Key Players Platelet Rich Plasma Treatment Product Solution and Service
3.7 Date of Enter into Platelet Rich Plasma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Platelet Rich Plasma Treatment Breakdown Data by Type
4.1 Global Platelet Rich Plasma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Platelet Rich Plasma Treatment Forecasted Market Size by Type (2022-2027)

5 Platelet Rich Plasma Treatment Breakdown Data by Application
5.1 Global Platelet Rich Plasma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Platelet Rich Plasma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Platelet Rich Plasma Treatment Market Size (2016-2027)
6.2 North America Platelet Rich Plasma Treatment Market Size by Type
6.2.1 North America Platelet Rich Plasma Treatment Market Size by Type (2016-2021)
6.2.2 North America Platelet Rich Plasma Treatment Market Size by Type (2022-2027)
6.2.3 North America Platelet Rich Plasma Treatment Market Size by Type (2016-2027)
6.3 North America Platelet Rich Plasma Treatment Market Size by Application
6.3.1 North America Platelet Rich Plasma Treatment Market Size by Application (2016-2021)
6.3.2 North America Platelet Rich Plasma Treatment Market Size by Application (2022-2027)
6.3.3 North America Platelet Rich Plasma Treatment Market Size by Application (2016-2027)
6.4 North America Platelet Rich Plasma Treatment Market Size by Country
6.4.1 North America Platelet Rich Plasma Treatment Market Size by Country (2016-2021)
6.4.2 North America Platelet Rich Plasma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Platelet Rich Plasma Treatment Market Size (2016-2027)
7.2 Europe Platelet Rich Plasma Treatment Market Size by Type
7.2.1 Europe Platelet Rich Plasma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Platelet Rich Plasma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Platelet Rich Plasma Treatment Market Size by Type (2016-2027)
7.3 Europe Platelet Rich Plasma Treatment Market Size by Application
7.3.1 Europe Platelet Rich Plasma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Platelet Rich Plasma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Platelet Rich Plasma Treatment Market Size by Application (2016-2027)
7.4 Europe Platelet Rich Plasma Treatment Market Size by Country
7.4.1 Europe Platelet Rich Plasma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Platelet Rich Plasma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Platelet Rich Plasma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Type
8.2.1 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Application
8.3.1 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Region
8.4.1 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Platelet Rich Plasma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Platelet Rich Plasma Treatment Market Size (2016-2027)
9.2 Latin America Platelet Rich Plasma Treatment Market Size by Type
9.2.1 Latin America Platelet Rich Plasma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Platelet Rich Plasma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Platelet Rich Plasma Treatment Market Size by Type (2016-2027)
9.3 Latin America Platelet Rich Plasma Treatment Market Size by Application
9.3.1 Latin America Platelet Rich Plasma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Platelet Rich Plasma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Platelet Rich Plasma Treatment Market Size by Application (2016-2027)
9.4 Latin America Platelet Rich Plasma Treatment Market Size by Country
9.4.1 Latin America Platelet Rich Plasma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Platelet Rich Plasma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Platelet Rich Plasma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Type
10.2.1 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Application
10.3.1 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Country
10.4.1 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Platelet Rich Plasma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Harvest Technologies
11.1.1 Harvest Technologies Company Details
11.1.2 Harvest Technologies Business Overview
11.1.3 Harvest Technologies Platelet Rich Plasma Treatment Introduction
11.1.4 Harvest Technologies Revenue in Platelet Rich Plasma Treatment Business (2016-2021)
11.1.5 Harvest Technologies Recent Development
11.2 DePuy Synthes
11.2.1 DePuy Synthes Company Details
11.2.2 DePuy Synthes Business Overview
11.2.3 DePuy Synthes Platelet Rich Plasma Treatment Introduction
11.2.4 DePuy Synthes Revenue in Platelet Rich Plasma Treatment Business (2016-2021)
11.2.5 DePuy Synthes Recent Development
11.3 Stryker
11.3.1 Stryker Company Details
11.3.2 Stryker Business Overview
11.3.3 Stryker Platelet Rich Plasma Treatment Introduction
11.3.4 Stryker Revenue in Platelet Rich Plasma Treatment Business (2016-2021)
11.3.5 Stryker Recent Development
11.4 Zimmer Biomet
11.4.1 Zimmer Biomet Company Details
11.4.2 Zimmer Biomet Business Overview
11.4.3 Zimmer Biomet Platelet Rich Plasma Treatment Introduction
11.4.4 Zimmer Biomet Revenue in Platelet Rich Plasma Treatment Business (2016-2021)
11.4.5 Zimmer Biomet Recent Development
11.5 Arthrex
11.5.1 Arthrex Company Details
11.5.2 Arthrex Business Overview
11.5.3 Arthrex Platelet Rich Plasma Treatment Introduction
11.5.4 Arthrex Revenue in Platelet Rich Plasma Treatment Business (2016-2021)
11.5.5 Arthrex Recent Development
11.6 Exactech
11.6.1 Exactech Company Details
11.6.2 Exactech Business Overview
11.6.3 Exactech Platelet Rich Plasma Treatment Introduction
11.6.4 Exactech Revenue in Platelet Rich Plasma Treatment Business (2016-2021)
11.6.5 Exactech Recent Development
11.7 Emcyte Corporation
11.7.1 Emcyte Corporation Company Details
11.7.2 Emcyte Corporation Business Overview
11.7.3 Emcyte Corporation Platelet Rich Plasma Treatment Introduction
11.7.4 Emcyte Corporation Revenue in Platelet Rich Plasma Treatment Business (2016-2021)
11.7.5 Emcyte Corporation Recent Development
11.8 Arteriocyte
11.8.1 Arteriocyte Company Details
11.8.2 Arteriocyte Business Overview
11.8.3 Arteriocyte Platelet Rich Plasma Treatment Introduction
11.8.4 Arteriocyte Revenue in Platelet Rich Plasma Treatment Business (2016-2021)
11.8.5 Arteriocyte Recent Development
11.9 Adilyfe
11.9.1 Adilyfe Company Details
11.9.2 Adilyfe Business Overview
11.9.3 Adilyfe Platelet Rich Plasma Treatment Introduction
11.9.4 Adilyfe Revenue in Platelet Rich Plasma Treatment Business (2016-2021)
11.9.5 Adilyfe Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Platelet Rich Plasma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of P-PRP
Table 3. Key Players of L-PRF
Table 4. Key Players of L-PRP
Table 5. Global Platelet Rich Plasma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Platelet Rich Plasma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Platelet Rich Plasma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Platelet Rich Plasma Treatment Market Share by Regions (2016-2021)
Table 9. Global Platelet Rich Plasma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Platelet Rich Plasma Treatment Market Share by Regions (2022-2027)
Table 11. Platelet Rich Plasma Treatment Market Trends
Table 12. Platelet Rich Plasma Treatment Market Drivers
Table 13. Platelet Rich Plasma Treatment Market Challenges
Table 14. Platelet Rich Plasma Treatment Market Restraints
Table 15. Global Platelet Rich Plasma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Platelet Rich Plasma Treatment Market Share by Players (2016-2021)
Table 17. Global Top Platelet Rich Plasma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platelet Rich Plasma Treatment as of 2020)
Table 18. Ranking of Global Top Platelet Rich Plasma Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Platelet Rich Plasma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Platelet Rich Plasma Treatment Product Solution and Service
Table 22. Date of Enter into Platelet Rich Plasma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Platelet Rich Plasma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Platelet Rich Plasma Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Platelet Rich Plasma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Platelet Rich Plasma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Platelet Rich Plasma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Platelet Rich Plasma Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Platelet Rich Plasma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Platelet Rich Plasma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Platelet Rich Plasma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Platelet Rich Plasma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Platelet Rich Plasma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Platelet Rich Plasma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Platelet Rich Plasma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Platelet Rich Plasma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Platelet Rich Plasma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Platelet Rich Plasma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Platelet Rich Plasma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Platelet Rich Plasma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Platelet Rich Plasma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Platelet Rich Plasma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Platelet Rich Plasma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Platelet Rich Plasma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Platelet Rich Plasma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Platelet Rich Plasma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Platelet Rich Plasma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Platelet Rich Plasma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Platelet Rich Plasma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Platelet Rich Plasma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Platelet Rich Plasma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Platelet Rich Plasma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Platelet Rich Plasma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Platelet Rich Plasma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Platelet Rich Plasma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Platelet Rich Plasma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Platelet Rich Plasma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Platelet Rich Plasma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Platelet Rich Plasma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Platelet Rich Plasma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Harvest Technologies Company Details
Table 63. Harvest Technologies Business Overview
Table 64. Harvest Technologies Platelet Rich Plasma Treatment Product
Table 65. Harvest Technologies Revenue in Platelet Rich Plasma Treatment Business (2016-2021) & (US$ Million)
Table 66. Harvest Technologies Recent Development
Table 67. DePuy Synthes Company Details
Table 68. DePuy Synthes Business Overview
Table 69. DePuy Synthes Platelet Rich Plasma Treatment Product
Table 70. DePuy Synthes Revenue in Platelet Rich Plasma Treatment Business (2016-2021) & (US$ Million)
Table 71. DePuy Synthes Recent Development
Table 72. Stryker Company Details
Table 73. Stryker Business Overview
Table 74. Stryker Platelet Rich Plasma Treatment Product
Table 75. Stryker Revenue in Platelet Rich Plasma Treatment Business (2016-2021) & (US$ Million)
Table 76. Stryker Recent Development
Table 77. Zimmer Biomet Company Details
Table 78. Zimmer Biomet Business Overview
Table 79. Zimmer Biomet Platelet Rich Plasma Treatment Product
Table 80. Zimmer Biomet Revenue in Platelet Rich Plasma Treatment Business (2016-2021) & (US$ Million)
Table 81. Zimmer Biomet Recent Development
Table 82. Arthrex Company Details
Table 83. Arthrex Business Overview
Table 84. Arthrex Platelet Rich Plasma Treatment Product
Table 85. Arthrex Revenue in Platelet Rich Plasma Treatment Business (2016-2021) & (US$ Million)
Table 86. Arthrex Recent Development
Table 87. Exactech Company Details
Table 88. Exactech Business Overview
Table 89. Exactech Platelet Rich Plasma Treatment Product
Table 90. Exactech Revenue in Platelet Rich Plasma Treatment Business (2016-2021) & (US$ Million)
Table 91. Exactech Recent Development
Table 92. Emcyte Corporation Company Details
Table 93. Emcyte Corporation Business Overview
Table 94. Emcyte Corporation Platelet Rich Plasma Treatment Product
Table 95. Emcyte Corporation Revenue in Platelet Rich Plasma Treatment Business (2016-2021) & (US$ Million)
Table 96. Emcyte Corporation Recent Development
Table 97. Arteriocyte Company Details
Table 98. Arteriocyte Business Overview
Table 99. Arteriocyte Revenue in Platelet Rich Plasma Treatment Business (2016-2021) & (US$ Million)
Table 100. Arteriocyte Recent Development
Table 101. Adilyfe Company Details
Table 102. Adilyfe Business Overview
Table 103. Adilyfe Platelet Rich Plasma Treatment Product
Table 104. Adilyfe Revenue in Platelet Rich Plasma Treatment Business (2016-2021) & (US$ Million)
Table 105. Adilyfe Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Platelet Rich Plasma Treatment Market Share by Type: 2020 VS 2027
Figure 2. P-PRP Features
Figure 3. L-PRF Features
Figure 4. L-PRP Features
Figure 5. Global Platelet Rich Plasma Treatment Market Share by Application: 2020 VS 2027
Figure 6. Orthopedic Surgery Case Studies
Figure 7. Cosmetic Surgery Case Studies
Figure 8. General Surgery Case Studies
Figure 9. Other Surgeries Case Studies
Figure 10. Platelet Rich Plasma Treatment Report Years Considered
Figure 11. Global Platelet Rich Plasma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Platelet Rich Plasma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Platelet Rich Plasma Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Platelet Rich Plasma Treatment Market Share by Regions (2022-2027)
Figure 15. Global Platelet Rich Plasma Treatment Market Share by Players in 2020
Figure 16. Global Top Platelet Rich Plasma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platelet Rich Plasma Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Platelet Rich Plasma Treatment Revenue in 2020
Figure 18. Global Platelet Rich Plasma Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Platelet Rich Plasma Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Platelet Rich Plasma Treatment Market Share by Type (2016-2027)
Figure 22. North America Platelet Rich Plasma Treatment Market Share by Application (2016-2027)
Figure 23. North America Platelet Rich Plasma Treatment Market Share by Country (2016-2027)
Figure 24. United States Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Platelet Rich Plasma Treatment Market Share by Type (2016-2027)
Figure 28. Europe Platelet Rich Plasma Treatment Market Share by Application (2016-2027)
Figure 29. Europe Platelet Rich Plasma Treatment Market Share by Country (2016-2027)
Figure 30. Germany Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Platelet Rich Plasma Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Platelet Rich Plasma Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Platelet Rich Plasma Treatment Market Share by Region (2016-2027)
Figure 40. China Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Platelet Rich Plasma Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Platelet Rich Plasma Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Platelet Rich Plasma Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Platelet Rich Plasma Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Platelet Rich Plasma Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Platelet Rich Plasma Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Platelet Rich Plasma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Harvest Technologies Revenue Growth Rate in Platelet Rich Plasma Treatment Business (2016-2021)
Figure 60. DePuy Synthes Revenue Growth Rate in Platelet Rich Plasma Treatment Business (2016-2021)
Figure 61. Stryker Revenue Growth Rate in Platelet Rich Plasma Treatment Business (2016-2021)
Figure 62. Zimmer Biomet Revenue Growth Rate in Platelet Rich Plasma Treatment Business (2016-2021)
Figure 63. Arthrex Revenue Growth Rate in Platelet Rich Plasma Treatment Business (2016-2021)
Figure 64. Exactech Revenue Growth Rate in Platelet Rich Plasma Treatment Business (2016-2021)
Figure 65. Emcyte Corporation Revenue Growth Rate in Platelet Rich Plasma Treatment Business (2016-2021)
Figure 66. Arteriocyte Revenue Growth Rate in Platelet Rich Plasma Treatment Business (2016-2021)
Figure 67. Adilyfe Revenue Growth Rate in Platelet Rich Plasma Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の多血小板血漿療法市場規模・現状・予測（2021年-2027年）

Global Platelet-rich Plasma Therapy Market Size, Status and Forecast 2021-2027
QFJ1-5954 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、多血小板血漿療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（純PRP、白血球豊富型PRP、白血球豊富型フィブリン（L-PRF））、用途別市場規模（整形外科、皮膚科、心筋損傷、歯科、神経損傷、その他...

世界の脱毛症幹細胞＆多血小板血漿（PRP）治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2021-2027
QFJ1-6020 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、脱毛症幹細胞＆多血小板血漿（PRP）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（多血小板血漿注射、幹細胞治療）、用途別市場規模（皮膚科クリニック、病院）、主要地域別市場規模（北米、アメリカ、欧...

多血小板血漿療法のグローバル市場：規模・現状・予測2019-2025

Global Platelet-rich Plasma Therapy Market Size, Status and Forecast 2019-2025
QYR9NV18295 2019年11月18日 97Pages
※当調査レポートでは、多血小板血漿療法の世界市場について調査・分析し、多血小板血漿療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（純粋なPRP、白血球が豊富なPRP、白血球が豊富なフィブリン（L...

多血小板血漿療法のグローバル市場：規模・現状・予測2019-2025

世界の自己調整血漿療法市場規模・現状・予測（2021年-2027年）

Global Autologous Conditioned Plasma Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3874 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、自己調整血漿療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（純粋多血小板血漿(P-PRP)、白血球・多血小板血漿(LPRP)、純粋多血小板血漿フィブリン(P-PRF)、白血球・多血小板血漿フィブリ...

世界の組換え血漿タンパク質市場規模・現状・予測（2021年-2027年）

Global Recombinant Plasma Proteins Market Size, Status and Forecast 2021-2027
QFJ1-4799 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、組換え血漿タンパク質の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（チャイニーズハムスター卵巣（CHO）細胞株、ベイビーハムスター腎臓（BHK）細胞株、ヒト胎児腎臓（HEK）細胞株、その他）、用途別市...

世界の迅速血漿レアギン検査市場規模・現状・予測（2021年-2027年）

Global Rapid Plasma Reagin Test Market Size, Status and Forecast 2021-2027
QFJ1-4794 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、迅速血漿レアギン検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体検査、蛍光抗体検査、蛍光トレポネマ抗体吸収検査、トリポネーマ・パリダム血球凝集反応アッセイ）、用途別市場規模（病院...

世界の血漿由来人血清アルブミン検査市場規模・現状・予測（2021年-2027年）

Global Plasma-derived Human Serum Albumin Test Market Size, Status and Forecast 2021-2027
QFJ1-4717 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、血漿由来人血清アルブミン検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品、その他）、用途別市場規模（病院・クリニック、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の血漿誘導体市場規模・現状・予測（2021年-2027年）

Global Blood Plasma Derivatives Market Size, Status and Forecast 2021-2027
QFJ1-5628 2021年6月 124Pages
QYResearch社発行の本調査レポートでは、血漿誘導体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルブミン、ファクターVIII、ファクターIX、イムノグロブリン、ハイパーイムンググロブリン、その他）、用途別市場規模（病院、診療所、その他）...

世界の動物血漿＆誘導体市場規模・現状・予測（2021年-2027年）

Global Animal Blood Plasma and Derivatives Market Size, Status and Forecast 2021-2027
QFJ1-3809 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、動物血漿＆誘導体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫グロブリン、フィブリノーゲン、血清アルブミン、ウシ胎児血清、トロンビン、新生子牛血清）、用途別市場規模（食品＆飲料産業、医薬品、化粧...

世界の多血小板血漿療法市場規模・現状・予測（2021年-2027年） Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine. Market Analys…
世界の脱毛症幹細胞＆多血小板血漿（PRP）治療市場規模・現状・予測（2021年-2027年） Platelet-rich plasma (PRP) has emerged as a new treatment modality in regenerative plastic surgery, and preliminary evidence suggests that it might have a beneficial role in hair regrowth. Market Analysis and Insights: Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market The gl…
多血小板血漿療法のグローバル市場：規模・現状・予測2019-2025 Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.In 2018, the g…
多血小板血漿療法のグローバル市場：規模・現状・予測2019-2025 Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.In 2018, the g…
世界の自己調整血漿療法市場規模・現状・予測（2021年-2027年） Autologous conditioned plasma therapy is used to treat a range of problems, such as musculoskeletal injuries, sports injuries and trauma. Today, among other things, it is widely used to treat skin ulcers, sports injuries, and cosmetic surgery. The growing demand for user-friendly treatment procedure…